• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

reneuron - Articles and news items

retinitis-pigmentosa

First patient treated in trial of ReNeuron’s retinitis pigmentosa cell therapy

Industry news / 15 March 2016 / Victoria White

ReNeuron has demonstrated that its Human Retinal Progenitor Cells (hRPCs) improve visual acuity in preclinical models of retinal degeneration…

reneuron-retinitis-pigmentosa

FDA grants Fast Track designation to ReNeuron’s retinitis pigmentosa cell therapy candidate

Industry news / 22 May 2015 / Victoria White

The FDA has granted Fast Track designation to ReNeuron’s human Retinal Progenitor Cell (hRPC) therapy candidate for retinitis pigmentosa…

ctx-stem-cell

ReNeuron provides more data from Phase I trial of CTX stem cell therapy for stroke patients

Industry news / 21 April 2015 / Victoria White

ReNeuron has provided a further and final update on the PISCES Phase I clinical trial of its CTX stem cell therapy for disabled stroke patients…

ReNeuron

ReNeuron files application to commence Phase I/II clinical trial with its stem cell therapy candidate for retinitis pigmentosa

Industry news / 13 April 2015 / Victoria White

ReNeuron has announced that it has filed an IND application with the FDA to commence a Phase I/II clinical trial with its hRPC therapy candidate for RP…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +